Correlation Between EFFECTOR Therapeutics and Surrozen Warrant

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both EFFECTOR Therapeutics and Surrozen Warrant at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining EFFECTOR Therapeutics and Surrozen Warrant into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between EFFECTOR Therapeutics and Surrozen Warrant, you can compare the effects of market volatilities on EFFECTOR Therapeutics and Surrozen Warrant and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in EFFECTOR Therapeutics with a short position of Surrozen Warrant. Check out your portfolio center. Please also check ongoing floating volatility patterns of EFFECTOR Therapeutics and Surrozen Warrant.

Diversification Opportunities for EFFECTOR Therapeutics and Surrozen Warrant

0.42
  Correlation Coefficient

Very weak diversification

The 3 months correlation between EFFECTOR and Surrozen is 0.42. Overlapping area represents the amount of risk that can be diversified away by holding EFFECTOR Therapeutics and Surrozen Warrant in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Surrozen Warrant and EFFECTOR Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on EFFECTOR Therapeutics are associated (or correlated) with Surrozen Warrant. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Surrozen Warrant has no effect on the direction of EFFECTOR Therapeutics i.e., EFFECTOR Therapeutics and Surrozen Warrant go up and down completely randomly.

Pair Corralation between EFFECTOR Therapeutics and Surrozen Warrant

Assuming the 90 days horizon EFFECTOR Therapeutics is expected to generate 181.53 times less return on investment than Surrozen Warrant. But when comparing it to its historical volatility, EFFECTOR Therapeutics is 6.47 times less risky than Surrozen Warrant. It trades about 0.01 of its potential returns per unit of risk. Surrozen Warrant is currently generating about 0.22 of returns per unit of risk over similar time horizon. If you would invest  4.78  in Surrozen Warrant on September 1, 2024 and sell it today you would lose (2.81) from holding Surrozen Warrant or give up 58.79% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthWeak
Accuracy68.57%
ValuesDaily Returns

EFFECTOR Therapeutics  vs.  Surrozen Warrant

 Performance 
       Timeline  
EFFECTOR Therapeutics 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days EFFECTOR Therapeutics has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of fairly stable basic indicators, EFFECTOR Therapeutics is not utilizing all of its potentials. The latest stock price fuss, may contribute to near-short-term losses for the sophisticated investors.
Surrozen Warrant 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Good
Over the last 90 days Surrozen Warrant has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of fairly unfluctuating basic indicators, Surrozen Warrant showed solid returns over the last few months and may actually be approaching a breakup point.

EFFECTOR Therapeutics and Surrozen Warrant Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with EFFECTOR Therapeutics and Surrozen Warrant

The main advantage of trading using opposite EFFECTOR Therapeutics and Surrozen Warrant positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if EFFECTOR Therapeutics position performs unexpectedly, Surrozen Warrant can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Surrozen Warrant will offset losses from the drop in Surrozen Warrant's long position.
The idea behind EFFECTOR Therapeutics and Surrozen Warrant pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Comparator module to compare the composition, asset allocations and performance of any two portfolios in your account.

Other Complementary Tools

Portfolio Backtesting
Avoid under-diversification and over-optimization by backtesting your portfolios
Commodity Directory
Find actively traded commodities issued by global exchanges
Positions Ratings
Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance
Fundamentals Comparison
Compare fundamentals across multiple equities to find investing opportunities
Portfolio File Import
Quickly import all of your third-party portfolios from your local drive in csv format